Belite Bio Reports Full-Year 2022 Operational Highlights and Financial Results
Go back to Belite Bio Reports Full-Year 2022 Operational Highlights and Financial Results| (NASDAQ: BLTE) | Delayed: 164.53 +1.32 (0.81%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $163.21 | 52 Week High | $ | |||
| Open | $161.81 | 52 Week Low | $ | |||
| Day High | $164.53 | P/E | N/A | |||
| Day Low | $160.15 | EPS | $ | |||
| Volume | 53,040 | |||||
| (NASDAQ: BLTE) | Delayed: 164.53 +1.32 (0.81%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $163.21 | 52 Week High | $ | |||
| Open | $161.81 | 52 Week Low | $ | |||
| Day High | $164.53 | P/E | N/A | |||
| Day Low | $160.15 | EPS | $ | |||
| Volume | 53,040 | |||||

